Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Biomarkers and genetic polymorphisms of one-carbon metabolism and risk of lymphoid cancers Unhee Lim NCI, DCEG, NEB PLCO Apr 21, 2006 2005-0025
Biomarkers for Head and Neck Cancer Uday Kumbhar Innotech Precision Medicine PLCO Jul 8, 2024 PLCO-1571
Biomarkers of Exposure and Response to Coffee Intake Erikka Loftfield National Cancer Institute PLCO Mar 20, 2020 PLCO-599
Biopsy Recommendation in Prostate Cancer Using Machine Learning Techniques TAHA KHAN FAST-NUCES Karachi PLCO Oct 16, 2017 PLCO-314
Biorepository Robert Garver University of Alabama at Birmingham NLST Jun 6, 2003 2003-90016
Biospecimen collection in the PLCO trial Danielle Carrick Westat PLCO Jul 1, 2006 2006-0024
Bisphosphonates as Chemoprevention Sharon Hensley Alford Henry Ford Health System PLCO Jul 8, 2010 2009-0264
Black Participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Fred L Stallings CDC PLCO Jul 1, 2006 2006-0235
Bladder Cancer Data Visualization OMAR GALDAMEZ CRUZ CENTRO DE DISEÑO Y COMUNICACION, S.C. PLCO Aug 2, 2022 PLCO-1011
Bladder Cancer Incidence and Smoking Adrien Bernstein None PLCO Jul 5, 2016 PLCO-216
Blockchain-based information system for medical image transfer Jianjing Lin Rensselaer Polytechnic Institute NLST May 28, 2019 NLST-515
Blood-based biomarkers as a complement to CT screening for lung cancer Edwin Ostrin University of Texas MD Anderson Cancer Center NLST Jul 29, 2020 NLST-698
Blood-based biomarkers for personalized risk assessment of breast and ovarian cancers Johannes Fahrmann University of Texas MD Anderson Cancer Center PLCO Jul 1, 2023 2022-0048
Blood-based biomarkers for risk assessment and early detection of colorectal cancers Samir Hanash University of Texas MD Anderson Cancer Center PLCO Feb 23, 2023 2022-0046
Blood-based gene expression markers for early detection of lung cancer Melissa Rotunno NCI, DCEG, GEB PLCO Oct 22, 2012 2012-0247
Blood groups and inflammatory marker levels Charles Rabkin DCEG PLCO Jul 17, 2020 PLCO-646
Blood metabolite profiles and risk of developing breast cancer in PLCO. Steven Moore Extramural PLCO Nov 11, 2013 2013-0255
Blood metabolite profiles and risk of developing endometrial cancer Mary Playdon Huntsman Cancer Institute PLCO Jun 29, 2017 2017-0020
Blood metabolomics, smoking and lung cancer risk Wei Jie Seow National University of Singapore PLCO Dec 16, 2019 PLCO-558
BMI and Impact on Screening for Prostate Cancer Robert Grubb Washington University School of Medicine in St. Louis PLCO Jul 1, 2006 2006-0034